ArticleBMC gastroenterology2026
Evaluating clinicopathological pattern and management of colorectal cancer for adult patients presenting at Queen Elizabeth Central Hospital: a 10-year retrospective review.
Article in BMC gastroenterology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundColorectal cancer (CRC) is the second leading cause of cancer mortality and the third prevalent cancer globally. In Sub-Saharan Africa (SSA), the incidence is increasing. This retrospective cross-sectional study evaluated clinicopathological pattern and management of CRC for adult patients presenting at Queen Elizabeth Central Hospital (QECH), Malawi.
methodsThe review of oncology and surgical register books identified patients diagnosed with CRC who presented between 2012 and 2022. The variables assessed were age, sex, HIV status, symptoms, family history, diagnostic approach, tumour site, histological diagnosis, treatment modality, and length of hospital stay (LOHS).
resultsThere were 192 patients identified with CRC. The median age was 45 years [interquartile range (IQR) = 43.5–60], with slight male predominance at 100 (52.08%). There were 23 (11.98%) patients with HIV infection and all were on treatment. Abdominal pain and rectal bleeding were the predominant symptoms occuring in 100 (52.08%) and 78 (40.63%) respectively. The mean duration of signs and symptoms was 7.6 months (SD = 4.6). Over half of the patients, 113 (58.85%) were in clinical stage IV. The majority were diagnosed at laparotomy 116 (60.42%), followed by colonoscopy 19 (9.90%). Out of the 192 participants, 110 (57.29%) had histology reports confirming CRC, while 82 (42.71%) had no histology reports. All the available histology reports showed adenocarcinoma. Surgery was the main treatment for 155 (80.73%) patients while chemotherapy was offered to 81 (42.19%) patients.
conclusionCRC at QECH is predominantly diagnosed in young patients at advanced stages. Screening younger age groups could improve with early diagnosis and management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.